D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 89 Citations 24,864 240 World Ranking 446 National Ranking 43
Medicine D-index 92 Citations 29,642 274 World Ranking 5525 National Ranking 515

Overview

What is she best known for?

The fields of study she is best known for:

  • Virus
  • Gene
  • Immune system

Sarah C. Gilbert focuses on Immunology, Virology, Immunogenicity, Vaccination and Vaccinia. Her Virology research includes themes of Cytotoxic T cell, Viral vector, Recombinant DNA and Antigen. Her Immunogenicity research incorporates themes from ELISPOT, Viral Vaccine, Adverse effect and Modified vaccinia Ankara.

Her studies deal with areas such as Clinical research, Clinical trial, Regimen, Heterologous and Reactogenicity as well as Vaccination. Her study in Vaccinia is interdisciplinary in nature, drawing from both Interferon and DNA vaccination. Her work carried out in the field of Plasmodium falciparum brings together such families of science as Antibody and Vaccine efficacy.

Her most cited work include:

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (671 citations)
  • Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara (636 citations)
  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (626 citations)

What are the main themes of her work throughout her whole career to date?

Sarah C. Gilbert mainly investigates Virology, Immunology, Vaccination, Immunogenicity and Antigen. Her work deals with themes such as Vaccinia, Plasmodium falciparum, Viral vector and Immune system, which intersect with Virology. Her Vaccinia study integrates concerns from other disciplines, such as Immunization and DNA vaccination.

Her study looks at the intersection of Immunology and topics like Cytotoxic T cell with CD8, Priming and Plasmodium berghei. Her studies deal with areas such as Cellular immunity, Heterologous, Regimen and Modified vaccinia Ankara as well as Vaccination. The various areas that Sarah C. Gilbert examines in her Immunogenicity study include ELISPOT, Viral Vaccine, Adenoviridae and Adjuvant.

She most often published in these fields:

  • Virology (73.56%)
  • Immunology (46.50%)
  • Vaccination (33.43%)

What were the highlights of her more recent work (between 2017-2021)?

  • Virology (73.56%)
  • Vaccination (33.43%)
  • Immunogenicity (33.13%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Virology, Vaccination, Immunogenicity, Virus and Antibody. Her Virology research is multidisciplinary, incorporating elements of Heterologous, Viral vector, Antigen and Severe acute respiratory syndrome coronavirus 2. Her study with Vaccination involves better knowledge in Immunology.

Sarah C. Gilbert has included themes like T cell, Booster dose, Viral Vaccine and Immunity in her Immunogenicity study. Her Virus study combines topics from a wide range of disciplines, such as Transmission, Vaccinia and Pandemic. Her Antibody research is multidisciplinary, relying on both Receptor, Viral replication and Recombinant DNA.

Between 2017 and 2021, her most popular works were:

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (671 citations)
  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (626 citations)
  • ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. (316 citations)

In her most recent research, the most cited papers focused on:

  • Virus
  • Gene
  • Immune system

Vaccination, Immunogenicity, Virology, Antibody and Adverse effect are her primary areas of study. Her work carried out in the field of Vaccination brings together such families of science as Virus, Viral load, Booster dose and Modified vaccinia Ankara. Her Virus research is multidisciplinary, incorporating perspectives in Vaccinia and Heterologous.

Sarah C. Gilbert is doing genetic studies as part of her Immunology and Immune system and Immunogenicity investigations. Sarah C. Gilbert has researched Virology in several fields, including Epitope and Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019. She interconnects Receptor and Coronavirus in the investigation of issues within Antibody.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

P M Folegatti;K J Ewer;P K Aley;B Angus.
The Lancet (2020)

875 Citations

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

Jörg Schneider;Sarah C. Gilbert;Tom J. Blanchard;Tomas Hanke.
Nature Medicine (1998)

828 Citations

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

M Voysey;Clemens Sac.;S A Madhi;L Y Weckx.
The Lancet (2021)

805 Citations

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

Helen McShane;Ansar A Pathan;Clare R Sander;Sheila M Keating.
Nature Medicine (2004)

735 Citations

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

Samuel J McConkey;William H H Reece;Vasee S Moorthy;Daniel Webster.
Nature Medicine (2003)

696 Citations

Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria.

C Ruwende;S C Khoo;R W Snow;S N Yates.
Nature (1995)

669 Citations

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.

Neeltje van Doremalen;Teresa Lambe;Alexandra Spencer;Sandra Belij-Rammerstorfer.
Nature (2020)

450 Citations

Upregulation of TGF-β, FOXP3, and CD4+CD25+ Regulatory T Cells Correlates with More Rapid Parasite Growth in Human Malaria Infection

Michael Walther;Jon Eric Tongren;Laura Andrews;Daniel Korbel.
Immunity (2005)

434 Citations

Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1

Tamara K. Berthoud;Matthew Hamill;Patrick J. Lillie;Lenias Hwenda.
Clinical Infectious Diseases (2011)

342 Citations

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

Daniel P. Webster;Susanna Dunachie;Jenni M. Vuola;Tamara Berthoud.
Proceedings of the National Academy of Sciences of the United States of America (2005)

317 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sarah C. Gilbert

Adrian V. S. Hill

Adrian V. S. Hill

University of Oxford

Publications: 201

Helen McShane

Helen McShane

University of Oxford

Publications: 100

Tomáš Hanke

Tomáš Hanke

University of Oxford

Publications: 99

Philip Bejon

Philip Bejon

University of Oxford

Publications: 86

Kevin Marsh

Kevin Marsh

University of Oxford

Publications: 78

Simon J. Draper

Simon J. Draper

University of Oxford

Publications: 73

Stephen J. Kent

Stephen J. Kent

University of Melbourne

Publications: 72

Mariano Esteban

Mariano Esteban

Spanish National Research Council

Publications: 70

Stephen L. Hoffman

Stephen L. Hoffman

Sanaria

Publications: 67

Andrew J. McMichael

Andrew J. McMichael

University of Oxford

Publications: 65

Denise L. Doolan

Denise L. Doolan

Australian Institute of Tropical Health and Medicine

Publications: 58

Magdalena Plebanski

Magdalena Plebanski

RMIT University

Publications: 56

Carole A. Long

Carole A. Long

National Institutes of Health

Publications: 53

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 53

Thomas L. Richie

Thomas L. Richie

Naval Medical Research Center

Publications: 52

Dan H. Barouch

Dan H. Barouch

Beth Israel Deaconess Medical Center

Publications: 52

Trending Scientists

Murali Kodialam

Murali Kodialam

Nokia (United States)

Mahidzal Dahari

Mahidzal Dahari

University of Malaya

Dan M. Ionel

Dan M. Ionel

University of Kentucky

Luiz B. Da Silva

Luiz B. Da Silva

Lawrence Livermore National Laboratory

Anders Riisager

Anders Riisager

Technical University of Denmark

Renato Noto

Renato Noto

University of Palermo

Weiwei Li

Weiwei Li

Beijing University of Chemical Technology

Gino Palumbo

Gino Palumbo

Hydro One (Canada)

Kamaljit S. Bawa

Kamaljit S. Bawa

University of Massachusetts Boston

Tomoichiro Asano

Tomoichiro Asano

Hiroshima University

Nadim J. Ajami

Nadim J. Ajami

The University of Texas MD Anderson Cancer Center

Guillaume St-Onge

Guillaume St-Onge

Université du Québec à Rimouski

James E. Overland

James E. Overland

Pacific Marine Environmental Laboratory

Katharine A. Phillips

Katharine A. Phillips

Brown University

Fruhling Rijsdijk

Fruhling Rijsdijk

King's College London

Mary O'Sullivan

Mary O'Sullivan

University of Limerick

Something went wrong. Please try again later.